Literature DB >> 15565374

Reduction of beta cell mass: partial insulin secretory compensation from the residual beta cell population in the nicotinamide-streptozotocin Göttingen minipig after oral glucose in vivo and in the perfused pancreas.

M O Larsen1, B Rolin, C F Gotfredsen, R D Carr, J J Holst.   

Abstract

AIMS/HYPOTHESIS: A progressive loss of beta cell function and mass are important contributory factors in the development and progression of type 2 diabetes. The aim of this study was to evaluate the effects of a primary reduction in beta cell mass on beta cell function in vivo and in the perfused pancreas and to relate these characteristics to beta cell mass.
METHODS: The beta cell mass of six Göttingen minipigs was reduced chemically (using 67 mg/kg nicotinamide and 125 mg/kg streptozotocin). Six untreated minipigs were kept as control animals. Insulin responses were evaluated in vivo using the mixed meal tolerance test (2 g/kg oral glucose) and in the isolated perfused pancreata from the same animals by stimulation with glucose, glucagon-like peptide-1 or arginine.
RESULTS: Beta cell mass was reduced in the beta-cell-reduced animals compared with the control minipigs (182+/-76 vs 464+/-156 mg, p<0.01). AUC(glucose) was increased in the beta-cell-reduced animals (1383+/-385 vs 853+/-113 mmol.l(-1).min in control minipigs, p<0.01), as was the insulin response to oral glucose per unit of beta cell mass (123+/-84 vs 56+/-24 pmol.l(-1).min.mg(-1), p<0.05). Total in vitro insulin secretion was increased per unit of beta cell mass in nicotinamide + streptozotocin pancreata compared to controls (83.7+/-45.9 vs 34.6+/-14.4 nmol/mg beta cells, p<0.05) with responses to glucose and glucagon-like peptide-1 showing a partial compensation for reduced beta cell mass, whereas no compensation was seen in response to arginine. CONCLUSIONS/
INTERPRETATION: A primary reduction in beta cell mass impairs glucose tolerance and leads to a compensatory increase in insulin secretion from the remaining beta cells after oral glucose in vivo, which is even more apparent in the perfused pancreas. It remains to be determined whether this compensation can be maintained in the long term.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15565374     DOI: 10.1007/s00125-004-1546-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Overstimulation and beta-cell function.

Authors:  V Grill; A Björklund
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

2.  The smooth fractionator.

Authors:  H J G Gundersen
Journal:  J Microsc       Date:  2002-09       Impact factor: 1.758

3.  Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.

Authors:  A Clark; C A Wells; I D Buley; J K Cruickshank; R I Vanhegan; D R Matthews; G J Cooper; R R Holman; R C Turner
Journal:  Diabetes Res       Date:  1988-12

4.  Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide.

Authors:  P Masiello; C Broca; R Gross; M Roye; M Manteghetti; D Hillaire-Buys; M Novelli; G Ribes
Journal:  Diabetes       Date:  1998-02       Impact factor: 9.461

5.  The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia.

Authors:  P Vague; J P Moulin
Journal:  Metabolism       Date:  1982-02       Impact factor: 8.694

6.  Secretory effects of secretin on isolated perfused porcine pancreas.

Authors:  S L Jensen; J Fahrenkrug; J J Holst; C Kühl; O V Nielsen; O B Schaffalitzky de Muckadell
Journal:  Am J Physiol       Date:  1978-10

7.  Enzyme immunoassay for intact human insulin in serum or plasma.

Authors:  L Andersen; B Dinesen; P N Jørgensen; F Poulsen; M E Røder
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

8.  Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects.

Authors:  K Saito; N Yaginuma; T Takahashi
Journal:  Tohoku J Exp Med       Date:  1979-11       Impact factor: 1.848

9.  The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

Authors:  W T Garvey; J M Olefsky; J Griffin; R F Hamman; O G Kolterman
Journal:  Diabetes       Date:  1985-03       Impact factor: 9.461

10.  Improved beta-cell survival and reduced insulitis in a type 1 diabetic rat model after treatment with a beta-cell-selective K(ATP) channel opener.

Authors:  Kresten Skak; Carsten F Gotfredsen; Dorthe Lundsgaard; John Bondo Hansen; Jeppe Sturis; Helle Markholst
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

View more
  1 in total

1.  A standardized method for in vivo mouse pancreas imaging and semiquantitative β cell mass measurement by dual isotope SPECT.

Authors:  Iris Mathijs; Catarina Xavier; Cindy Peleman; Vicky Caveliers; Maarten Brom; Martin Gotthardt; Pedro L Herrera; Tony Lahoutte; Luc Bouwens
Journal:  Mol Imaging Biol       Date:  2015-02       Impact factor: 3.488

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.